Stock listing

NASDAQ:IMGN ImmunoGen Inc Stock

Follow ImmunoGen Inc into a list and get an email when it puts out news.

Last close · NASDAQ:IMGN

$31.23 USD

Close on Feb 9, 2024 · No longer trades

Nov 17, 1989 to last close +228.7% · monthly closes, Nov 17, 1989 – Feb 9, 2024
Lowest – highest close
$0.844 – $43.81 USDSince Nov 17, 1989 · lowest Dec 24, 1997 · highest Nov 8, 2000

Delisted NASDAQ:IMGN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:IMGN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

ImmunoGen Inc on 6ix

Calls
11 calls with a replay · 11 with a transcript · latest Nov 2, 2023
Decks
8 decks · latest Jan 9, 2023

Events

CallWhenStatus
ImmunoGen (IMGN) Q3 2023 Earnings CallThu, Nov 02, 2023 · 8:00 AM ETReplay
ImmunoGen (IMGN) Q2 2023 Earnings CallMon, Jul 31, 2023 · 8:00 AM ETReplay
ImmunoGen (IMGN) Q1 2023 Earnings CallFri, Apr 28, 2023 · 8:00 AM ETReplay
ImmunoGen (IMGN) Q3 2022 Earnings CallFri, Nov 04, 2022 · 8:00 AM ETReplay
ImmunoGen (IMGN) Q2 2022 Earnings CallFri, Jul 29, 2022 · 8:30 AM ETReplay
ImmunoGen (IMGN) Q1 2022 Earnings CallFri, May 06, 2022 · 8:00 AM ETReplay
ImmunoGen (IMGN) Q4 2021 Earnings CallFri, Feb 25, 2022 · 8:00 AM ETReplay
ImmunoGen (IMGN) Q3 2021 Earnings CallFri, Oct 29, 2021 · 8:00 AM ETReplay
ImmunoGen (IMGN) Q2 2021 Earnings CallFri, Jul 30, 2021 · 8:00 AM ETReplay
ImmunoGen (IMGN) Q1 2021 Earnings CallMon, May 10, 2021 · 8:00 AM ETReplay
All 11 calls
CallWhenStatus
ImmunoGen (IMGN) Q3 2020 Earnings CallFri, Nov 06, 2020 · 8:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
JP Morgan Healthcare Conference 2023Conference31 slidesJan 9, 2023
JP Morgan Healthcare Conference 2022Conference31 slidesJan 10, 2022
J.P. Morgan Healthcare Conference 2021Conference24 slidesJan 11, 2021
Technical Presentation (December 2020)Technical17 slidesDec 7, 2020
Investor Presentation (January 2020)Investor deck23 slidesJan 13, 2020
Technical Presentation (September 2019)Technical24 slidesSep 30, 2019
Corporate Update (May 2018)Corporate update11 slidesMay 17, 2018
FY2016 Earnings PresentationEarnings22 slidesAug 4, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mark Alan Goldberg
Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past)
Director · Nov 8, 2011 – Feb 12, 2024 · Past
Mark Enyedy
Other companies: Charles River Laboratories International, Inc. (Director · Since at least May 20, 2025); BioMarin Pharmaceutical Inc. (Director · Since at least Dec 27, 2023); LogicBio Therapeutics Inc (Director · Mar 17, 2020 – Nov 16, 2022 · Past); Akebia Therapeutics, Inc. (Director · Dec 12, 2018 – Jun 5, 2020 · Past); Keryx Biopharmaceuticals Inc (Director · Jun 30, 2018 – Dec 12, 2018 · Past)
CHIEF EXECUTIVE OFFICER, Director · Feb 15, 2018 – Feb 12, 2024 · Past
Stuart Arbuckle
Other companies: Praxis Precision Medicines, Inc. (Director · Since at least Jan 8, 2026); Alnylam Pharmaceuticals, Inc. (Director · Since at least Jan 5, 2026); Rhythm Pharmaceuticals, Inc. (Director · Since at least Jul 23, 2019); Vertex Pharmaceuticals Incorporated (EVP, COO · Since at least May 25, 2016); Dare Bioscience, Inc. (Director · Jun 22, 2016 – Jan 3, 2017 · Past)
Director · Jan 23, 2018 – Feb 12, 2024 · Past
Dean Mitchell
Other companies: Praxis Precision Medicines, Inc. (Chairman of the Board · Since at least Oct 15, 2020); Theravance Biopharma, Inc. (Director · Since at least Apr 30, 2019); Kinnate Biopharma Inc (Director · Dec 2, 2020 – Apr 3, 2024 · Past); Precigen, Inc. (Director · Mar 8, 2020 – Mar 14, 2024 · Past)
Director · Mar 31, 2019 – Feb 12, 2024 · Past
Nicole Onetto
Other companies: Bolt Biotherapeutics, Inc. (Director · Since at least Dec 14, 2021); Viracta Therapeutics Inc (Director · Mar 26, 2021 – Jun 9, 2022 · Past); Sunesis Pharmaceuticals Inc (Director · Sep 17, 2019 – Jun 30, 2020 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Jun 11, 2019 · Past)
Director · Nov 12, 2013 – Nov 10, 2015 · Past
Isabel Kalofonos
Other companies: CG Oncology, Inc. (Chief Commercial Officer · Since at least Nov 18, 2026); Crinetics Pharmaceuticals, Inc. (Chief Commercial Officer · Since at least Dec 16, 2024)
SVP & CHIEF COMMERCIAL OFFICER · Apr 24, 2023 – Feb 12, 2024 · Past
Anna Berkenblit
Other companies: Surrozen, Inc. (Director · Since at least Jun 7, 2022)
SVP & CHIEF MEDICAL OFFICER · May 20, 2022 – Jun 30, 2023 · Past
David Brannon Johnston
Other companies: AVEO Pharmaceuticals Inc (Chief Financial Officer · Mar 11, 2010 – Oct 2, 2013 · Past)
Chief Financial Officer · Dec 30, 2013 – Jun 6, 2018 · Past
Stacy Ann Coen
Other companies: FibroBiologics, Inc. (Director · Since at least Jan 24, 2024)
SVP & CHIEF BUSINESS OFFICER · May 20, 2022 – Feb 12, 2024 · Past
Stephen C McCluski
Other companies: Monro, Inc. (Director · Since at least Aug 6, 2021)
Director · Jun 16, 2021 – Feb 12, 2024 · Past
All 11 people
PersonSeat
Craig BarrowsExecutive VP, General Counsel · Jul 20, 2012 – Feb 24, 2020 · Past

Open People

Log in to ask 6ix AI your own questions about ImmunoGen Inc.